The relationship between Direct to Consumer Advertising (DTCA) and asthma-related emergency department use among Medicaid-enrolled children

References

• Bloom B, Cohen RA, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2009. Vital Health Stat 2010;10:1–82
   Google Scholar
• Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: final data for 2006. Natl Vital Stat Rep 2009;57:1–134
   PubMedGoogle Scholar
• Akinbami LJ, Moorman JE, Bailey C, Zahran HS, King M, Johnson CA, Liu X. Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. NCHS Data Brief 2012;94:1–8
   PubMedGoogle Scholar
• Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469–478
   PubMed Web of Science ®Google Scholar
• Akinbami L. Advance data from vital and health statistics. Hyattsville, MD: National Center for Health Statistics; 2006:1–24
   Google Scholar
• National Heart, Lung and Blood Institute Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma Full Report 2007, Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute; 2007
   Google Scholar
• Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332–336
   PubMed Web of Science ®Google Scholar
• Camargo CA, Ramachandran S, Ryskina KL, Lewis BE, Legorreta AP. Association between common asthma therapies and recurrent asthma exacerbations in children enrolled in a state Medicaid plan. Am J Health Syst Pharm 2007;64:1054–1061
   PubMed Web of Science ®Google Scholar
• Piecoro LT, Potoski M, Talbert JC, Doherty DE. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population. Health Serv Res 2001;36:357–371
   PubMed Web of Science ®Google Scholar
• Butz A, Tsoukleris M, Donithan M, Hsu VD, Mudd K, Zuckerman IH, Bollinger ME. Patterns of Inhaled anti-inflammatory medication use in young underserved children with asthma. Pediatrics 2006;118:2504–2513
   PubMed Web of Science ®Google Scholar
• Finkelstein J, Barton MB, Donahue JG, Algatt-Bergstrom P, Markson LE, Platt R. Comparing asthma care for Medicaid and non-Medicaid children in a Health Maintenance Organization. Arch Pediatrics Adolescent Med 2000;154:563–568
   PubMedGoogle Scholar
• Conn KM, Halterman JS, Fisher SG, Yoos HL, Chin NP, Szilagyi PG. Parental beliefs about medications and medication adherence among urban children with asthma. Ambul Pediatr 2005;5:306–310
   PubMedGoogle Scholar
• David C. Preventive therapy for asthmatic children under Florida Medicaid: changes during the 1990s. J Asthma 2004;41:655–661
   PubMed Web of Science ®Google Scholar
• Finkelstein J, Lozano P, Farber HJ, Miroshnik I, Lieu TA. Underuse of controller medications among Medicaid-insured children with asthma. Arch Pediatrics Adolescent Med 2002;156:562–567
   PubMed Web of Science ®Google Scholar
• Wells K, Pladevall M, Peterson EL, Campbell J, Wang M, Lanfear DE, Williams LK. Race-ethnic differences in factors associated with inhaled steroid adherence among adults with asthma. Am J Respir Crit Care Med 2008;178:1194–1201
   PubMed Web of Science ®Google Scholar
• Calfee JE. Public policy issues in direct-to-consumer advertising of prescription drugs. J Publ Pol Market 2002;21:74–193
   Google Scholar
• Bradford D, Kleit AN, Neitert PJ, Steyer T, McIlwain T, Ornstein S. The effect of direct to consumer television advertising on the timing of treatment. Economic Inquiry 2009;48:306–322
   Google Scholar
• Hansen RA, Chen SY, Gaynes BN, Maciejewski ML. Relationship of pharmaceutical promotion to antidepressant switching and adherence: a retrospective cohort study. Psychiatr Serv 2010;61:1232–1238
   Google Scholar
• Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care 2004;42:1176–1185
   PubMed Web of Science ®Google Scholar
• Wosinska M. Direct-to-consumer advertising and drug therapy compliance. J Market Res 2005;42(3):323–332
   Web of Science ®Google Scholar
• Bradford WD, Kleit AN, Nietert PJ, Steyer T, McIlwain T, Ornstein S. How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior. Health Aff (Millwood) 2006;25:1371–1377
   PubMed Web of Science ®Google Scholar
• Bradford WD, Kleit AN, Nietert PJ, Ornstein S. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals. Clin Ther 2006;28:2105–2118; discussion 2104
   PubMed Web of Science ®Google Scholar
• Morgan S. Direct-to-consumer advertising and expenditure on prescription drugs: a comparison of experiences in the United States and Canada. Open Med 2007;1:e37–e45
   Google Scholar
• Mintzes B. For and against: direct to consumer advertising is medicalising normal human experience. BMJ 2002;324:908–909
   PubMed Web of Science ®Google Scholar
• Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A, Evans RG, et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ 2003;169:405–412
   PubMed Web of Science ®Google Scholar
• Datti B, Carter MW. The effect of direct-to-consumer advertising on prescription drug use by older adults. Drugs Aging 2006;23:71–81
   PubMed Web of Science ®Google Scholar
• Allison-Ottey S, Ruffin K, Allison K, Ottey CC. Assessing the impact of direct-to-consumer advertisements on the AA patient: a multisite survey of patients during the office visit. J Natl Med Assoc 2003;95:120–131
   PubMed Web of Science ®Google Scholar
• Morris AW, Gadson SL, Burroughs V. “For the good of the patient,” survey of the physicians of the National Medical Association regarding perceptions of DTC advertising, Part II, 2006. J Natl Med Assoc 2007;99:287–293
   PubMed Web of Science ®Google Scholar
• Adeoye S Bozic K. Direct to consumer advertising in healthcare: history, benefits, and concerns. Clin Orthop Relat Res 2007;457:96–104
   PubMed Web of Science ®Google Scholar
• Mastin T, Andsager JL, Choi J, Lee K. Health disparities and direct-to-consumer prescription drug advertising: a content analysis of targeted magazine genres, 1992–2002. Health Commun 2007;22:49–58
   PubMed Web of Science ®Google Scholar
• Murray E, Lo B, Pollack L, Donelan K, Lee K. Direct-to-consumer advertising: public perceptions of its effects on health behaviors, health care, and the doctor-patient relationship. J Am Board Fam Pract 2004;17:6–18
   PubMedGoogle Scholar
• Allison-Ottey SD, Ruffin K, Allison KB. “To do no harm” survey of NMA physicians regarding perceptions on DTC advertisements. National Medical Association. J Natl Med Assoc 2002;94:194–202
   PubMed Web of Science ®Google Scholar
• Calfee J, Winston C, Stempski R. Direct-to-consumer advertising and the demand for cholesterol reducing drugs. J Law Econ 2002;45:673–690
   Web of Science ®Google Scholar
• Friedman M, Gould J. Consumer attitudes and behaviors associated with direct-to-consumer prescription drug marketing. J Consum Market 2007;24:100–109
   Google Scholar
• Murray E, Lo B, Pollack L, Donelan K, Lee K. Direct-to-consumer advertising: physicians' views of its effects on quality of care and the doctor–patient relationship. J Am Board Fam Pract 2003;16:513–524
   PubMedGoogle Scholar
• Berger WE, Legorreta AP, Blaiss MS, Schneider EC, Luskin AT, Stempel DA, Suissa S, et al. The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Ann Allergy Asthma Immunol 2004;93:538–545
   PubMed Web of Science ®Google Scholar
• Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 1995;36:1–10
   PubMed Web of Science ®Google Scholar
• McRoy LC. The effects of direct to consumer advertising on healthcare utilization among Medicaid children with asthma [dissertation]. Birmingham, AL: University of Alabama Birmingham. Ann Arbor: ProQuest/UMI, 2012. (Publication No. 3512391)
   Google Scholar
• Avery RJ, Kenkel D, Lillard DR, Mathios A, Wang H. Health disparities and direct-to-consumer advertising of pharmaceutical products. Adv Health Econ Health Serv Res 2008;19:71–94
   PubMedGoogle Scholar
• Parnes B, Smith PC, Gilroy C, Quintela J, Emsermann CB, Dickinson LM, Westfall JM. Lack of impact of direct-to-consumer advertising on the physician-patient encounter in primary care: a SNOCAP report. Ann Fam Med 2009;7:41–46
   PubMed Web of Science ®Google Scholar
• Lee TA, Chang CL, Stephenson JJ, Sajjan SG, Maiese EM, Everett S, Allen-Ramey F. Impact of asthma controller medications on medical and economic resource utilization in adult asthma patients. Curr Med Res Opin 2010;26:2851–2860
   PubMed Web of Science ®Google Scholar
• Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma – United States, 1980–1999. MMWR Surveill Summ 2002;51:1–13
   PubMed Web of Science ®Google Scholar
• Akinbami LC. Centers for Disease, and S. Prevention National Center for Health. The state of childhood asthma, United States, 1980–2005. Adv Data 2006;381:1–24
   PubMedGoogle Scholar